Professionisti del settore sanitario
Endurant II Stent Graft Systems
EVAR Procedures
Questo sito utilizza cookies per salvare informazioni sul tuo computer. Alcune informazioni sono essenziali per il funzionamento del nostro sito, mentre altre ci aiutano a migliorare l’esperienza d’uso del sito da parte dell’utente. Continuando nella navigazione sul sito si accetta l’installazione di tali cookies. È possibile in qualsiasi momento modificare le preferenze concernenti i cookies. Per avere ulteriori informazioni consulta la nostra Cookie Policy Estesa.
Il tuo browser è obsoleto
Con un browser aggiornato, l'esperienza sul sito Web di Medtronic sarà migliore. Aggiorna il mio browser adesso.
Si, sono un operatore sanitario
Note: Ai sensi e per gli effetti dell’Art. 76 D.P.R. 445/2000 consapevole della responsabilità e delle conseguenze civili e penali previste in caso di dichiarazioni mendaci e/o formazione od uso di atti falsi, nonché in caso di esibizione atti contenenti dati non più corrispondenti a verità e consapevole altresì che qualora emerga la non veridicità del contenuto della presente decadranno i benefici per i quali la stessa è rilasciata confermo di essere un OPERATORE SANITARIO.
I contenuti presenti in questo sito contengono informazioni rivolte agli operatori sanitari, in quanto si riferiscono a prodotti rientranti nella categoria dei dispositivi medici che richiedono l’impiego o l’intervento da parte di professionisti del settore medico-sanitario.
Professionisti del settore sanitario
EVAR Procedures
Choose the AAA proven solution as varied as your patients. The Endurant™ II system family of products provides the standard of care with a legacy of clinical success for the treatment of abdominal aortic aneurysm (AAA). For the past 5 years, the Endurant II stent graft system has been used in 1 out of 2 EVAR cases.* Only the Endurant II stent graft has the deep clinical experience and favorable clinical outcomes designed to treat both straightforward and challenging anatomy.
All indications related to Endurant II/IIs Stent Graft System are not approved globally. Please check your local regulatory approval status. Refer to the complete Instructions for Use manual of the Endurant II/IIs stent graft system for the indications approved in your geography.
The Endurant II/IIs stent graft system is indicated for the endovascular treatment of infrarenal or juxtarenal abdominal aortic or aortoiliac aneurysms in patients with the following characteristics:
In addition, for treatment of infrarenal abdominal aortic or aortoiliac aneurysms, the following patient characteristics apply:
In addition, for treatment of juxtarenal abdominal aortic or aortoiliac aneurysms with the parallel graft technique, the following patient characteristics apply:
Note: The angle between the aortic and renal artery blood lumen centerlines is the renal take-off angulation. An angle of <90° is associated with a downward-pointed renal artery relative to the trajectory of the aortic centerline.
The Endurant II family:
Endurant IIs stent graft is a three-piece system that:
The Endurant IIs stent graft:
The Endurant II delivery system helps ensure precise control and accurate placement at every stage of deployment:
Tip capture delivery allows precise adjustment of position, proximally or distally, even after deployment of three stent rings. Control the release of the suprarenal stent and anchor pins with the back-end thumb wheel.
Endurant II Delivery System Controlled Deployment
Deployment, capture, and release of the Endurant II stent.
Deployment of the Endurant IIs Stent Graft
View an animation of the Endurant IIs stent graft deployment.
Maggiori informazioni
Less information (see less)
Deployment of the Endurant II Stent Graft
View an animation of the Endurant II stent deployment.
Maggiori informazioni
Less information (see less)
* Data on file at Medtronic.
† Bench test data on file at Medtronic. Bench test data may not be indicative of clinical performance.
‡ Data on file from the 178 de novo patients from the ENGAGE Post-Approval Study (PAS).
§ Delivery success = successful vascular access and delivery of the device to the intended anatomical treatment site. Deployment success = successful deployment of the device in the intended site and the successful removal of the delivery system. Endurant™ US IDE trial: Makaroun M. One-year outcomes of the US regulatory trial of the Endurant™ stent graft system. J Vasc Surg. 2011; 54:601–608.
Instructions for Use
Find this technical manual in the Medtronic Manual Library, in the product labeling supplied with each device, or by calling 877-526-7890.
Use this tool to plan case specifics such as sizing and placement.
722KB
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETBF | 23 | 13 | C | 124 | EE | 18 |
ETBF | 23 | 13 | C | 145 | EE | 18 |
ETBF | 23 | 13 | C | 166 | EE | 18 |
ETBF | 23 | 16 | C | 124 | EE | 18 |
ETBF | 23 | 16 | C | 145 | EE | 18 |
ETBF | 23 | 16 | C | 166 | EE | 18 |
ETBF | 25 | 13 | C | 124 | EE | 18 |
ETBF | 25 | 13 | C | 145 | EE | 18 |
ETBF | 25 | 13 | C | 166 | EE | 18 |
ETBF | 25 | 16 | C | 124 | EE | 18 |
ETBF | 25 | 16 | C | 145 | EE | 18 |
ETBF | 25 | 16 | C | 166 | EE | 18 |
ETBF | 28 | 13 | C | 124 | EE | 18 |
ETBF | 28 | 13 | C | 145 | EE | 18 |
ETBF | 28 | 13 | C | 166 | EE | 18 |
ETBF | 28 | 16 | C | 124 | EE | 18 |
ETBF | 28 | 16 | C | 145 | EE | 18 |
ETBF | 28 | 16 | C | 166 | EE | 18 |
ETBF | 28 | 20 | C | 124 | EE | 18 |
ETBF | 28 | 20 | C | 145 | EE | 18 |
ETBF | 28 | 20 | C | 166 | EE | 18 |
ETBF | 32 | 16 | C | 124 | EE | 20 |
ETBF | 32 | 16 | C | 145 | EE | 20 |
ETBF | 32 | 16 | C | 166 | EE | 20 |
ETBF | 32 | 20 | C | 124 | EE | 20 |
ETBF | 32 | 20 | C | 145 | EE | 20 |
ETBF | 32 | 20 | C | 166 | EE | 20 |
ETBF | 36 | 16 | C | 145 | EE | 20 |
ETBF | 36 | 16 | C | 166 | EE | 20 |
ETBF | 36 | 20 | C | 145 | EE | 20 |
ETBF | 36 | 20 | C | 166 | EE | 20 |
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ESBF | 23 | 14 | C | 103 | EE | 18 |
ESBF | 25 | 14 | C | 103 | EE | 18 |
ESBF | 28 | 14 | C | 103 | EE | 18 |
ESBF | 32 | 14 | C | 103 | EE | 20 |
ESBF | 36 | 14 | C | 103 | EE | 20 |
Distal Graft |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
Total Contralateral Covered Length with EII/EIIs Bifurcated† |
Total Ipsilateral Covered Length with EIIs Bifurcated‡ |
|
---|---|---|---|---|---|---|---|---|
ETLW | 16 | 10 | C | 82 | EE | 14 | 136 | 155 |
ETLW | 16 | 10 | C | 93 | EE | 14 | 147 | 166 |
ETLW | 16 | 10 | C | 124 | EE | 14 | 178 | 177-197 |
ETLW | 16 | 10 | C | 156 | EE | 16 | 210 | 209-229 |
ETLW | 16 | 10 | C | 199 | EE | 16 | 253 | 252-272 |
ETLW | 16 | 13 | C | 82 | EE | 14 | 136 | 155 |
ETLW | 16 | 13 | C | 93 | EE | 14 | 147 | 166 |
ETLW | 16 | 13 | C | 124 | EE | 14 | 178 | 177-197 |
ETLW | 16 | 13 | C | 156 | EE | 16 | 210 | 209-229 |
ETLW | 16 | 13 | C | 199 | EE | 16 | 253 | 252-272 |
ETLW | 16 | 16 | C | 82 | EE | 14 | 136 | 135-155 |
ETLW | 16 | 16 | C | 93 | EE | 14 | 147 | 146-166 |
ETLW | 16 | 16 | C | 124 | EE | 14 | 178 | 177-197 |
ETLW | 16 | 16 | C | 156 | EE | 16 | 210 | 209-229 |
ETLW | 16 | 16 | C | 199 | EE | 16 | 253 | 252-272 |
ETLW | 16 | 20 | C | 82 | EE | 16 | 136 | 155 |
ETLW | 16 | 20 | C | 93 | EE | 16 | 147 | 166 |
ETLW | 16 | 20 | C | 124 | EE | 16 | 178 | 177-197 |
ETLW | 16 | 20 | C | 156 | EE | 16 | 210 | 209-229 |
ETLW | 16 | 20 | C | 199 | EE | 16 | 253 | 252-272 |
ETLW | 16 | 24 | C | 82 | EE | 16 | 136 | 155 |
ETLW | 16 | 24 | C | 93 | EE | 16 | 147 | 166 |
ETLW | 16 | 24 | C | 124 | EE | 16 | 178 | 177-197 |
ETLW | 16 | 24 | C | 156 | EE | 16 | 210 | 209-229 |
ETLW | 16 | 24 | C | 199 | EE | 16 | 253 | 252-272 |
ETLW | 16 | 28 | C | 82 | EE | 16 | 136 | 155 |
ETLW | 16 | 28 | C | 93 | EE | 16 | 147 | 166 |
ETLW | 16 | 28 | C | 124 | EE | 16 | 178 | 177-197 |
ETLW | 16 | 28 | C | 156 | EE | 16 | 210 | 209-229 |
ETLW | 16 | 28 | C | 199 | EE | 16 | 253 | 252-272 |
* The limb mates with the AUI stent graft on the ipsilateral side.
† These calculations assume the minimum 30 mm overlap between the bifurcated stent graft and the contralateral iliac limb per the Endurant II Stent Graft System Instructions For Use. When using the 124 mm length bifurcated stent graft, subtract 10 mm from Total Contralateral Covered Length with Bifurcated.
‡ The 3-5 stent overlap is available only with select limbs. Please refer to the Instructions For Use for more information.
Proximal Graft |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETCF | 23 | 23 | C | 49 | EE | 18 |
ETCF | 25 | 25 | C | 49 | EE | 18 |
ETCF | 28 | 28 | C | 49 | EE | 18 |
ETCF | 32 | 32 | C | 49 | EE | 20 |
ETCF | 36 | 36 | C | 49 | EE | 20 |
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETTF | 23 | 23 | C | 70 | EE | 18 |
ETTF | 25 | 25 | C | 70 | EE | 18 |
ETTF | 28 | 28 | C | 70 | EE | 18 |
ETTF | 32 | 32 | C | 70 | EE | 20 |
ETTF | 36 | 36 | C | 70 | EE | 20 |
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETUF | 23 | 14 | C | 102 | EE | 18 |
ETUF | 25 | 14 | C | 102 | EE | 18 |
ETUF | 28 | 14 | C | 102 | EE | 18 |
ETUF | 32 | 14 | C | 102 | EE | 20 |
ETUF | 36 | 14 | C | 102 | EE | 20 |
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETEW | 10 | 10 | C | 82 | EE | 14 |
ETEW | 13 | 13 | C | 82 | EE | 14 |
ETEW | 20 | 20 | C | 82 | EE | 16 |
ETEW | 24 | 24 | C | 82 | EE | 16 |
ETEW | 28 | 28 | C | 82 | EE | 18 |
Medtronic Italia S.p.A. Società soggetta ad attività di direzione e coordinamento da parte di Medtronic PLC.
Cap. soc. € 1.200.487,00 - Registro Imprese N. 281327 Tribunale Milano - R.E.A. N. 1275682 - Cod. Fisc./P.IVA 09238800156.
Sede Legale e Uffici Via Varesina, 162 Edificio Raimondi - 20156 Milano.